European shares rise as investors buy dips, shrug off US tariff threats

European shares advanced on Wednesday, with the STOXX 600 gaining 0.3%, as investors capitalized on recent market weakness despite looming U.S. tariff threats. Strong corporate results from Commerzbank and Siemens Energy boosted their shares by nearly 1% and 1.2% respectively, while the healthcare sector declined 0.7%, weighed by a 1.3% drop in Novo Nordisk following its maintained full-year outlook after a recent 2025 sales cut and new U.S. tariff warnings on pharmaceutical imports.

Analysis

European equities are exhibiting a 'buy-the-dip' mentality, with the STOXX 600 advancing 0.3% for a third session despite overarching trade uncertainties. This market-level strength, however, masks significant sector divergence driven by company-specific fundamentals and targeted geopolitical pressures. Positive momentum is concentrated in financials and industrials, evidenced by Commerzbank (CBKG) rising nearly 1% on a quarterly profit beat and raised full-year outlook, and Siemens Energy (SIEGn) gaining 1.2% after signaling it would hit the upper end of its 2025 growth estimates. In stark contrast, the healthcare sector fell 0.7%, dragged down by a 1.3% drop in Novo Nordisk (NVO) after it maintained its full-year outlook, a move perceived negatively following a recent slash to its 2025 sales guidance. The pressure on healthcare is compounded by a new U.S. threat to impose tariffs on pharmaceuticals, while Switzerland's SMI index also dipped 0.1% ahead of a separate, imminent 39% U.S. tariff.

Key Decisions for Investors

• Consider overweighting European industrial and financial stocks with strong guidance, like Siemens Energy and Commerzbank, while remaining cautious on the healthcare sector due to negative outlooks and specific tariff risks.
• For Novo Nordisk, the combination of a disappointing 2025 sales outlook, subsequent cost-cutting, and the new U.S. tariff threat warrants a re-evaluation of risk, as multiple negative factors are converging on the stock.
• Closely monitor U.S. trade policy developments, as the market's current ability to overlook tariff risks may be fleeting, especially for export-heavy sectors and regions like Switzerland facing direct impacts.